Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
Busch M, Abel K, Li J, Piatak M Jr, Lifson JD, Miller CJ.
Busch M, et al. Among authors: lifson jd.
Vaccine. 2005 Jul 1;23(31):4036-47. doi: 10.1016/j.vaccine.2005.03.013. Epub 2005 Apr 9.
Vaccine. 2005.
PMID: 15963361
Previously, we have shown that inoculation with a proviral plasmid encoding SHIV 89.6 (pMA SHIV-89.6) results in systemic infection that is delayed compared to SHIV 89.6 virus inoculation [Busch M, Lu D, Fritts L, Lifson JD, Miller CJ. Comparison of virology and imm …
Previously, we have shown that inoculation with a proviral plasmid encoding SHIV 89.6 (pMA SHIV-89.6) results in systemic infection that is …